Jill M. Quigley's Net Worth
$124 Thousand
Who is Jill M. Quigley?
Jill M. Quigley does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Terns Pharmaceuticals, Inc., Passage BIO, Inc., and Chemomab Therapeutics Ltd..
SEC CIK
Jill M. Quigley's CIK is 0001799780
Past Insider Trading and Trends
2021 was Jill M. Quigley's most active year for acquiring shares with 4 total transactions. Jill M. Quigley's most active month to acquire stocks was the month of May. 2024 was Jill M. Quigley's most active year for disposing of shares, totalling 4 transactions. Jill M. Quigley's most active month to dispose stocks was the month of June. 2021 saw Jill M. Quigley paying a total of $507,124.05 for 215,273 shares, this is the most they've acquired in one year. In 2024 Jill M. Quigley cashed out on 29,530 shares for a total of $147,660.06, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Terns Pharmaceuticals, Inc. (TERN) Snapshot price: $7.99
Sr. Advisor & Strategy Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
$5.91 | -$140,982.30 | 15K |
Sep 9
| |||
Form 4
|
—
|
0
|
$5.91 | -$120,787.76 | 30K |
Jul 15 - Jul 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 10
| |||
Form 4
| +100.00% | 15K |
—
|
—
| 30K |
Jan 23
| |||
Form 4
|
∞
| 15K |
—
|
—
| 15K |
Nov 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 28
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Passage BIO, Inc. (PASG) Snapshot price: $0.7
Chief Operating Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +24.25% | 71.97K |
$0.23 | $16,554.25 | 368.75K |
Dec 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 16
| |||
Form 4
| -0.44% | -1.30K |
$30.01 | -$39,011.05 | 295.28K |
Scheduled
|
Jan 20
| ||
Form 4
| +5.81% | 16.3K |
$30.10 | $490,569.80 | 296.58K |
Scheduled
|
Jan 14
| ||
Form 4
| +0.81% | 2.5K |
$18.00 | $45,000.00 | 312.49K |
Mar 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 27
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Chemomab Therapeutics Ltd. (CMMB) Snapshot price: $1.95
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 16 - Jun 16
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||